Found: 26
Select item for more details and to access through your institution.
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 9, p. 2692, doi. 10.1007/s12094-023-03205-6
- By:
- Publication type:
- Article
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 10, p. 726, doi. 10.1007/s12094-012-0856-5
- By:
- Publication type:
- Article
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 8, p. 606, doi. 10.1007/s12094-012-0843-x
- By:
- Publication type:
- Article
SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 7, p. 528, doi. 10.1007/s12094-012-0836-9
- By:
- Publication type:
- Article
Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 11, p. 798, doi. 10.1007/s12094-011-0736-4
- By:
- Publication type:
- Article
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS).
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 8, p. 545, doi. 10.1007/s12094-011-0695-9
- By:
- Publication type:
- Article
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 3, p. 179, doi. 10.1007/s12094-011-0637-6
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of advanced colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 11, p. 729, doi. 10.1007/s12094-010-0587-4
- By:
- Publication type:
- Article
Expression of EGFR, HER-2/ neu and KIT in germ cell tumours.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 6, p. 443, doi. 10.1007/s12094-010-0532-6
- By:
- Publication type:
- Article
The insulin-like growth factor pathway as a target for cancer therapy.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 5, p. 326, doi. 10.1007/s12094-010-0514-8
- By:
- Publication type:
- Article
Inhibiting PI3K as a therapeutic strategy against cancer.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 9, p. 572, doi. 10.1007/s12094-009-0407-x
- By:
- Publication type:
- Article
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 7, p. 446, doi. 10.1007/s12094-009-0383-1
- By:
- Publication type:
- Article
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 1, p. 52, doi. 10.1007/s12094-008-0153-5
- By:
- Publication type:
- Article
Envolving treatment of fever and neutropenia in cancer patients.
- Published in:
- Clinical & Translational Oncology, 2002, v. 4, n. 6, p. 297, doi. 10.1007/BF02832104
- By:
- Publication type:
- Article
Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 2, p. 3440, doi. 10.3390/ijms14023440
- By:
- Publication type:
- Article
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.
- Published in:
- Cancer & Metastasis Reviews, 2011, v. 30, p. 19, doi. 10.1007/s10555-011-9291-2
- By:
- Publication type:
- Article
MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090524
- By:
- Publication type:
- Article
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2901-1
- By:
- Publication type:
- Article
Epithelial-Mesenchymal Transition Markers in the Differential Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 1, p. 61, doi. 10.1309/AJCPIV40ISTBXRAX
- By:
- Publication type:
- Article
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 5, p. 1031
- By:
- Publication type:
- Article
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy.
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. e328, doi. 10.1093/oncolo/oyab041
- By:
- Publication type:
- Article
Sunitinib and Evofosfamide (TH‐302) in Systemic Treatment‐Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE‐1408 Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 941, doi. 10.1002/onco.13885
- By:
- Publication type:
- Article
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407).
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 745, doi. 10.1634/theoncologist.2020-0033
- By:
- Publication type:
- Article
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 38, doi. 10.1634/theoncologist.2017-0622
- By:
- Publication type:
- Article
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133
- By:
- Publication type:
- Article